Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study ; volume:24 ; number:1 ; day:26 ; month:4 ; year:2024 ; pages:1-12 ; date:12.2024
BMC cancer ; 24, Heft 1 (26.4.2024), 1-12, 12.2024
- Urheber
-
Xiong, Hao
Zhang, Huitao
Bai, Jun
Li, Yanhong
Li, Lijuan
Zhang, Liansheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12301-x
- URN
-
urn:nbn:de:101:1-2407092102374.956380193978
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xiong, Hao
- Zhang, Huitao
- Bai, Jun
- Li, Yanhong
- Li, Lijuan
- Zhang, Liansheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
New mouse models of myeloproliferative neoplasms
Molecular pathogenesis of the myeloproliferative neoplasms
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Hypercalcemia as a biomarker of myeloproliferative neoplasms?
Modelling of disease progression in myeloproliferative neoplasms
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms
Molecular basis and clonal evolution of myeloproliferative neoplasms
Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Molecular pathogenesis of the myeloproliferative neoplasms
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Hypercalcemia as a biomarker of myeloproliferative neoplasms?
Modelling of disease progression in myeloproliferative neoplasms
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms
Molecular basis and clonal evolution of myeloproliferative neoplasms
Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Molecular pathogenesis of the myeloproliferative neoplasms
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Hypercalcemia as a biomarker of myeloproliferative neoplasms?
Modelling of disease progression in myeloproliferative neoplasms
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms
Molecular basis and clonal evolution of myeloproliferative neoplasms
Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
Targeted therapies for myeloproliferative neoplasms